China’s Mabwell Bioscience and US-based Aditum Bio have launched Kalexo Bio, a new company, to develop a new small ...

Aditum’s newly formed biotech, dubbed Kalexo Bio, will develop the asset for patients with elevated cholesterol, or ...

Arrowhead Pharmaceuticals (NASDAQ:ARWR) has entered into a global partnership with Novartis (NYSE:NVS), for the development of ARO-SNCA, the company's siRNA therapy aimed at treating synucleinopathies ...

REDWOOD CITY, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced ...

Argo Biopharmaceutical Co., Ltd. (Argo Biopharma), a clinical-stage small interfering RNA (siRNA) therapeutics company, today announced that the National Medical Products Administration of China (NMPA ...

For Novartis, the Argo deal marked the second billion-dollar RNA-based deal in a day. A few hours prior, the company ...

SAN DIEGO & SHANGHAI--(BUSINESS WIRE)--Sirius Therapeutics today announced that preliminary data from its Phase 1 clinical trial of SRSD107, a next generation siRNA therapeutic under clinical ...

Codexis, Inc. recently presented data at the TIDES USA annual meeting, showcasing their ECO Synthesis platform's effectiveness in manufacturing siRNA therapeutics. Their findings emphasized reduced ...

Obesity is a global health crisis, but treatments often cause significant side effects, including nausea, vomiting and muscle loss, and are difficult to adhere to over time. The INHBE gene, found in ...